Prognostic Factors of the Overall Survival and Disease Progressionin Advanced Non-Small Cell Lung Cancer Patients in India: MiniReview
DOI:
https://doi.org/10.47363/JCCSR/2022(4)202Keywords:
Lung cancer, Chemotherapy, Radiotherapy, Prognostic factor, NSCLCAbstract
Lung cancer is the most prevalent cancer among females and males, carrying the highest cancer-related mortality rates worldwide. Nearly two-thirds of patients present in the advanced stage at diagnosis requiring palliative therapy with chemotherapy and often radiotherapy, giving a variable response, too. Knowledge of prognostic factors might guide in tailoring the therapy in resource-limited countries. Hence, we reviewed the prognostic factors affecting overall survival and disease progression in advanced non-small-cell lung cancer patients.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Clinical Case Studies Reviews & Reports

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.